Assessment of Microorganisms and Host Response In Liver Diseases
Conditions: Gut Microbiome; Liver Diseases Sponsors: University of Aberdeen Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 4, 2024 Category: Research Source Type: clinical trials
Combining Gene Variants to Improve Risk Prediction for Metabolic (Dysfunction)- Associated Fatty Liver Disease and Its Progression to Cirrhosis in Indian Individuals With Type 2 Diabetes
Conditions: Type2diabetes Sponsors: Medanta, The Medicity, India Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 1, 2024 Category: Research Source Type: clinical trials
Genomic Medicine Risk Assessment Care for Everyone - Implementation Phase
Conditions: Cardiovascular Diseases; Cancer; Liver Diseases; Hyperthermia Interventions: Behavioral: Disease Risk Assessment Sponsors: Duke University; National Human Genome Research Institute (NHGRI) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 26, 2024 Category: Research Source Type: clinical trials
Safety Study to Evaluate the Occurrence of EFAD in Pediatric Patients With PNAC Who Require More Than Eight Weeks of Omegaven Treatment
Conditions: Parenteral Nutrition Associated Liver Disease (PNALD); Essential Fatty Acid Deficiency; Malnutrition; Pediatric ALL Interventions: Drug: Omegaven ® (fish oil triglycerides) Injectable Emulsion Sponsors: Fresenius Kabi Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 23, 2024 Category: Research Source Type: clinical trials
A Study to Test How Avenciguat (BI 685509) is Taken up in the Body of People With and Without Liver Problems
Conditions: Healthy; Liver Diseases Interventions: Drug: Avenciguat (BI 685509) Sponsors: Boehringer Ingelheim Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 22, 2024 Category: Research Source Type: clinical trials
A Multicenter, Randomized, Placebo Controlled, Double-blinded, Phase 4 to Evaluate the Efficacy and Safety of DWJ1464 in Patients With Chronic Liver Disease
Conditions: Chronic Liver Disease Interventions: Drug: DWJ1464; Drug: Placebo of DWJ1464 Sponsors: Daewoong Pharmaceutical Co. LTD. Enrolling by invitation (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 22, 2024 Category: Research Source Type: clinical trials
Enhancing Alcohol Treatment Engagement in Associated Liver Disease (ALD) Patients
Conditions: Alcohol-related Liver Disease; Liver Diseases Interventions: Behavioral: ENGAGE-ALD Application (APP); Behavioral: Treatment Facilitation bundle; Behavioral: Enhanced Usual Care Sponsors: University of Michigan; National Institute on Alcohol Abuse and Alcoholism (NIAAA) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 21, 2024 Category: Research Source Type: clinical trials
Prolonged Release Pirfenidone Versus Placebo in Compensated Cirrhosis.
Conditions: Liver Fibrosis; Cirrhosis, Liver; Chronic Liver Disease Interventions: Drug: Pirfenidone 1200 mg; Drug: Pirfenidone 1800 mg; Drug: Placebo Sponsors: Jorge L Poo Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 20, 2024 Category: Research Source Type: clinical trials
Evaluation of the Performance of Direct Portal Pressure Measurement by Endoscopic Ultrasound in a Large Cohort of Patients With Advanced Chronic Liver Disease of Different Etiologies and Newly Diagnosed Clinically Significant Portal Hypertension (EVADIPP)
Conditions: Portal Hypertension Interventions: Device: EUS PPG measurement Sponsors: Fondazione Policlinico Universitario Agostino Gemelli IRCCS Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 19, 2024 Category: Research Source Type: clinical trials
Efficacy Evaluation of Chang Geng Healthy Drink on Patients With Non-alcoholic Fatty Liver Disease
Conditions: Non-Alcoholic Fatty Liver Disease Interventions: Other: Chang Geng Healthy Drink Sponsors: Chang Gung Memorial Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 19, 2024 Category: Research Source Type: clinical trials
Different Exercise Modalities in the Treatment of NAFLD and Their Impact on Myokines
Conditions: NAFLD; Nonalcoholic Fatty Liver Disease; Fatty Liver, Nonalcoholic; Fatty Liver Interventions: Other: Exercise; Behavioral: Motivational Interviewing Sponsors: Yeditepe University; TUB İTAK Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 14, 2024 Category: Research Source Type: clinical trials
A Clinical Study of Curcuvail ® in Patients With Non-alcoholic Fatty Liver Disease
Conditions: Fatty Liver Without Mention of Alcohol Interventions: Drug: Test Product: Curcuvail ® 250mg capsule (Curcuma longa Extractcontaining 35% Curcuminoids); Drug: Placebo product Sponsors: COD Research Private Ltd Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 13, 2024 Category: Research Source Type: clinical trials
Efficacy of Canagliflozin Versus Metformin in Women With Polycystic Ovary Syndrome
Conditions: Polycystic Ovary Syndrome; Non-Alcoholic Fatty Liver Disease Interventions: Drug: Canagliflozin 100mg Tab; Drug: Metformin Hydrochloride Sponsors: Ping Li,MD Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 13, 2024 Category: Research Source Type: clinical trials
Effect of a Food Supplementation With a Combined Food Supplement on Lipid Pattern, Indexes of Non-alcoholic Fatty Liver Disease and Systemic Inflammation
Conditions: Hypercholesterolemia Interventions: Dietary Supplement: Dietary Supplement; Other: Placebo Sponsors: University of Bologna Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 7, 2024 Category: Research Source Type: clinical trials
Clinical Trials Using HepatoKeeper Herbal Essentials to Treat Non-alcoholic Fatty Liver Disease and Metabolic Factors
Conditions: Non-alcoholic Fatty Liver Disease; Liver Fibrosis; Liver Injury Interventions: Drug: Ganwei; Drug: Metformin; Drug: Placebo Sponsors: Taipei City Hospital; The One Biopharmaceutical Co., Ltd. Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 6, 2024 Category: Research Source Type: clinical trials
